Albion Financial Group »

Trevi Therapeutics shares owned by Albion Financial Group

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Albion Financial Group from 13F filings

Historical chart of Albion Financial Group investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Albion Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Albion Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $187k 10k 18.65

More positions owned by Albion Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr 0-3 Mth Treasury (SGOV)
Cisco Systems (CSCO)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Broadcom (AVGO)

View all positions for Albion Financial Group

Top funds holding Trevi Therapeutics

NEA Management Company
FMR
BlackRock
Frazier Life Sciences Management
Wellington Management Company
Vanguard Capital Management
Vivo Capital
Woodline Partners
Vestal Point Capital
MPM Oncology Impact Management
Frontier Capital Management
Geode Capital Management
Marshall Wace
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics